Health
Ozempic could help reduce Alzheimer’s risk for some, study suggests: ‘Shifting the paradigm’
Ozempic used to help cure arthritis pain: Report
Fox News medical contributor Dr. Marc Siegel joined ‘Fox & Friends’ to discuss his take on Ozempic being used to cure arthritis pain and why some doctors are warning some medications can affect heat sensitivity.
Semaglutide medications — such as Ozempic, the popular diabetes drug — have been linked to a reduced risk of Alzheimer’s disease for certain groups.
A new study, which was led by researchers at Case Western Reserve University in Cleveland, Ohio, revealed that patients who were prescribed semaglutide had a “significantly lower risk” of developing Alzheimer’s compared to those taking other types of anti-diabetic medications, according to a press release.
The researchers analyzed three years of medical records for nearly one million type 2 diabetes patients in the U.S.
NEW ALZHEIMER’S RESEARCH REVEALS ‘QUIET’ PHASE OF THE DISEASE, BEFORE SYMPTOMS APPEAR
The findings were published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association on Thursday.
Semaglutide medications have been linked to a reduced risk of Alzheimer’s disease for certain groups. (iStock)
“Our study provides promising real-world evidence suggesting that semaglutide could be beneficial in preventing or slowing down the development of AD,” lead author and biomedical informatics professor Rong Xu told Fox News Digital.
“The underlying mechanisms remain unknown, and future mechanistic studies and clinical trials are necessary to confirm the effects.”
ALZHEIMER’S DISEASE COULD BE SLOWED BY BOOSTING A CERTAIN PROTEIN IN THE BRAIN, RESEARCHERS SAY
Alzheimer’s is the seventh-leading cause of death in the U.S., according to the Centers for Disease Control and Prevention, taking around 120,000 lives each year.
Unlocking potential benefits
Semaglutide, the active ingredient in Novo Nordisk’s Ozempic, is a GLP-1 molecule that regulates blood sugar in diabetes patients.
It is also the active ingredient in Wegovy, Ozempic’s counterpart that is used to treat obesity.
Semaglutide, the active ingredient in Novo Nordisk’s Ozempic, is a GLP-1 molecule that regulates blood sugar in diabetes patients. (REUTERS/Hollie Adams/File Photo)
The findings suggest that there could be potential beneficial effects of semaglutide in preventing or slowing down the development of Alzheimer’s in high-risk populations, such as patients with type 2 diabetes, Xu noted.
“This can provide some guidance in the choice of anti-diabetic medications for diabetes management and, at the same time, for preventing Alzheimer’s disease,” she said.
MEAT CONSUMPTION LINKED TO HIGHER TYPE 2 DIABETES RISK IN OBSERVATIONAL STUDY
Dr. Sue Decotiis, MD, a New York City weight-loss doctor, said she was not surprised by the study’s discovery of the extra GLP-1 benefits.
“We know that GLP-1 drugs treat insulin resistance, which has a positive impact on the whole body – cardiovascular health, neurovascular health, decreased risk of stroke and better cognitive function,” Decotiis, who was not involved in the research, told Fox News Digital.
Semaglutide is also the active ingredient in Wegovy, Ozempic’s counterpart that is used to treat obesity. (Michael Siluk/UCG/Universal Images Group via Getty Images)
Dr. Brett Osborn, a Florida neurosurgeon and longevity doctor who often prescribes Ozempic to his patients, said this study reinforces how metabolic health influences neurodegeneration.
“The connection becomes even more apparent when considering the links between obesity, chronic inflammation and conditions like Alzheimer’s disease, often referred to as ‘type 3 diabetes’ due to its association with insulin resistance in the brain,” Osborn, who also was not involved in Case Western’s research, told Fox News Digital.
“GLP-1s treat insulin resistance, which has a positive impact on the whole body – including better cognitive function.”
In people with diabetes, a byproduct of insulin resistance is an increase in inflammation, Osborn noted, which is a “key driver” of neurodegeneration and cognitive decline.
“This suggests that effective management of insulin resistance and systemic inflammation reduction may be pivotal in slowing or preventing neurodegenerative diseases,” he said.
‘Shifting the paradigm’
Osborn agrees that the preventive effects of GLP-1 drugs will likely extend across various conditions.
“These drugs will ultimately be employed not just for diabetes, but as preventative and therapeutic agents for nearly all non-infectious age-related diseases, as well as conditions like alcoholism and drug addiction,” he said.
In people with diabetes, a byproduct of insulin resistance is an increase in inflammation, which is a “key driver” of neurodegeneration and cognitive decline, according to a doctor. (iStock)
While the study doesn’t claim that GLP-1s are a cure for Alzheimer’s, Osborn said, “It shifts the paradigm by addressing the underlying risk factors for Alzheimer’s rather than just its symptoms.”
“It suggests a more comprehensive approach — one that tackles insulin resistance, obesity and inflammation,” he went on.
By improving insulin sensitivity and reducing inflammation, these medications could provide direct benefits for not only the brain, but the entire body, he suggested.
“After all, most age-related conditions share common underpinnings and vary only by which part of the body is affected,” Osborn said. “It’s simply a matter of geography.”
Alzheimer’s is the seventh-leading cause of death in the U.S., according to the Centers for Disease Control and Prevention, taking around 120,000 lives each year. (iStock)
Decotiis said she expects to see “more and more widespread benefits” from using this category of drugs, but that more studies are needed to prove that they slow the progression of Alzheimer’s.
“There needs to be a clear indication from the FDA to use these drugs for Alzheimer’s specifically in order for them to be covered by insurance,” she added.
“Most age-related conditions share common underpinnings — it’s simply a matter of geography.”
Xu reiterated that these findings “cannot be used to justify off-label prescription of semaglutide for Alzheimer’s disease prevention and treatment.”
“For this to happen, randomized clinical trials are necessary,” she said.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
The researcher also acknowledged that the study had some limitations.
“This is a retrospective cohort study with inherent limitations related to uncontrolled or unmeasured confounding and biases,” she said.
“These drugs will ultimately be employed not just for diabetes, but as preventative and therapeutic agents for nearly all non-infectious age-related diseases, as well as conditions like alcoholism and drug addiction,” a doctor predicted. (iStock)
“Further research into semaglutide’s use will need to be further investigated through randomized clinical trials so alternative drugs can be tested as potential treatment for this debilitating illness.”
The study received funding from the National Institute on Aging and the National Center for Advancing Translational Sciences.
For more Health articles, visit www.foxnews.com/health
When contacted by Fox News Digital, Ozempic maker Novo Nordisk issued the following statement.
“Novo Nordisk welcomes independent research investigating the safety, efficacy and clinical utility of our products.”
A company spokesperson also stated that Novo Nordisk is conducting its own research into the effectiveness of oral semaglutide in early Alzheimer’s disease, with expected completion in 2025.
Health
How Well Will You Age? Take Our Quiz to Find Out.
Every day we’re faced with a zillion small choices: Go to sleep early, or watch one more episode of that Netflix drama. Call an old friend to catch up, or cruise social media. Of course, no single action will guarantee a long, healthy life or doom you to an early grave. But those little daily decisions do add up, and over the long term they can make a difference when it comes to both your longevity and your health span, the amount of life spent in relatively good health.
Scroll through this theoretical “day in the life” and select the option that best fits your typical day. Not every situation will apply perfectly, but think about which choice you’d be most likely to make. This isn’t a formal scientific assessment. The goal here isn’t to assign you a “good” or “bad” score, but to help you understand the central factors that shape the way we age and how long we live.
Health
Red hair may be increasing as study points to surprising evolution trend
NEWYou can now listen to Fox News articles!
A study from Harvard Medical School indicates natural selection has favored the red hair gene, resulting in a potential increase in the number of redheaded people as humanity continues to evolve.
By analyzing nearly 16,000 ancient genomes spanning 10,000 years, researchers identified a list of traits that nature is actively pushing forward. Among the most prominent were the genetic variants for red hair.
“Perhaps having red hair was beneficial 4,000 years ago, or perhaps it came along for the ride with a more important trait,” the authors noted.
22 HEALTH CARE PREDICTIONS FOR 2025 FROM MEDICAL RESEARCHERS
The study, published in the journal Nature, relied on a large database of ancient DNA from West Eurasia. Using new computing methods, the team was able to filter out random fluctuations in DNA to identify what it called “directional selection.”
Directional selection happens when a particular version of a gene gives an organism a strong survival or reproductive advantage, causing it to become more common in a population faster than it would by chance, according to experts.
Directional selection is when a specific gene provides such significant benefits that it rises in frequency across a population much faster than random chance. (iStock)
Prior to this study, scientists only knew of about 21 such instances in human history, one of which was lactose tolerance. This new research uncovered hundreds more.
“With these new techniques and a large amount of ancient genomic data, we can now watch how selection shaped biology in real time,” Ali Akbari, first author of the study and senior staff scientist in the lab of Harvard geneticist David Reich, said in a press release.
COMMON EATING HABIT MAY TRIGGER PREMATURE IMMUNE SYSTEM AGING, STUDY FINDS
The data showed that genetic markers for red hair are among 479 gene variants that have been strongly favored over the past 10,000 years. One likely explanation, the researchers said, is a major shift in human history: the transition to farming.
Scientists have long pointed to vitamin D synthesis as a likely driver for the rise of traits like fair skin and light hair. (iStock)
As humans moved away from hunting and gathering and settled into agricultural societies, their environment and behavior changed radically, triggering an evolutionary “acceleration.”
CLICK HERE FOR MORE HEALTH STORIES
While the Harvard study provides the first definitive statistical proof that red hair was actively selected during the rise of farming, the researchers noted that the exact prehistoric benefit still requires more study.
However, scientists have long pointed to vitamin D synthesis as a likely driver for the rise of these light-pigmented traits in northern climates.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
While redheads remain a minority of the global population today, the Harvard study’s analysis suggests that they may not be an evolutionary accident.
While redheads remain a minority of the global population today, the Harvard study’s analysis suggests they may not be an evolutionary accident. (iStock)
Instead, the red hair trait was “boosted” by natural selection as humans adapted to the challenges of a modern world, according to the researchers.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
The researchers urged caution in how these findings are interpreted.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
“What a variant is associated with now is not necessarily why an allele propagated,” the authors noted.
Health
Aging in Place: How Technology Might Help You Grow Old at Home
Dr. Megan Jack, a neurosurgeon in Cleveland, often works 60 or 70 hours a week. And she’s completely unavailable when she’s in the operating room. That makes it tough to be a caregiver for her 76-year-old mother, who lives in a separate unit on Dr. Jack’s property, 30 minutes away from the hospital.
To help care for her mother, who has Alzheimer’s disease, Dr. Jack uses an array of high-tech tools, some of which didn’t exist just a few years ago. She manages her mother’s medications with a smart pill box. She changes her television channels with an app, sends appointment reminders through a digital message board — and, with her mother’s blessing, uses cameras for communication and monitoring.
“It’s been invaluable that I can both make sure she’s safe and make sure everything is going well,” Dr. Jack said, “but also give her the independence and the freedom that she still deserves.”
America is aging rapidly. Roughly 11,000 people are turning 65 each day in the United States. And many of them — 75 percent of people over 50, according to AARP’s most recent survey, from 2024 — hope to spend their remaining years in the comfort of their homes, rather than in assisted-living or other care facilities.
One thing that could help fulfill those wishes is the budding field of “age tech,” which encompasses tools that support older adults. Industry experts say that age tech is making homes safer for older adults and is easing the minds of their caregivers, especially those who live far away or work outside the home.
Dr. Jack said that age tech had “really allowed me to integrate caregiving into my life, as opposed to caregiving taking over my life.”
The age tech boom
If older adults don’t have loved ones who are both close by and able to help, they might believe they don’t have a ton of options. They can live independently, or, if they can afford it and qualify medically, they can move to an assisted-living facility or a nursing home, without a lot of choices in between. In-home help can be expensive without Medicaid and can also be difficult to find, given the serious shortage of home care workers.
Age tech can help bridge some important gaps, said Emily Nabors, the associate director of innovation at the National Council on Aging, a nonprofit advocacy group. Already, AARP reports that 25 percent of caregivers are remotely monitoring their loved ones with apps, videos or wearables, nearly double the percentage from five years ago.
“We used to say homes are the health care settings of the future, but they really are health care settings now,” Ms. Nabors said. “Aging in place is very realistic.”
More than 700 companies are in AARP’s AgeTech Collaborative, a group that connects businesses, nonprofits and funders to help get new technologies off the ground. Altogether, the collaborative’s start-ups have raised nearly $1 billion in the past four years.
The products include smart walkers, glasses with lenses that provide real-time captions of conversations for those with hearing issues, and a concierge service that connects older people to drivers and deliveries, even if they don’t have a smartphone.
Ms. Nabors does foresee some affordability and access barriers to age tech, including the lack of high-speed internet in rural areas, but she said one vital resource would be local aging agencies, which can offer advice and, sometimes, free support.
Janet Marasa leaned on the agency near her home in Rockland County, N.Y., to get a free robotic pet for her mother, Carol DeMaio, 80, who has dementia. The pets, manufactured by a company called Joy for All, aim to offer emotional support without the upkeep.
Ms. DeMaio named the robotic dog Sabrina, after a golden retriever who died. The new Sabrina stays at the foot of her bed at night. As soon as Ms. DeMaio stirs awake, the dog reacts. “She said it gives her a reason to get up in the morning,” Ms. Marasa said.
The dog has been a boon to her, too. “It provides comfort and interaction that I can’t provide every second,” said Ms. Marasa, who lives with her mother but works full time for the county government. “It gives her something that she can feel like is totally her own.”
In Broward County, Fla., where the population of residents over 85 is expected to nearly triple over the next few decades, the local agency on aging has used state and federal money and private grants to provide technologies to nearly 4,000 of the county’s seniors at no cost.
Its offerings include a company that uses radar to sense falls and a program that allows seniors to make video calls through their televisions.
“The possibilities are endless,” Charlotte Mather-Taylor, the agency’s chief executive, said. “It’s pretty great to see all the new technology coming out so quickly, and I think that can only benefit our older population and also our caregivers.”
Here comes A.I.
Even technologies not specifically marketed as age tech can help older adults maintain their independence, said Laurie Orlov, founder of the blog Aging and Health Technology Watch. She pointed to video-calling and telehealth platforms; remotely controlled thermostats and lights; and smart speakers, doorbells and watches.
“All technology can be customized to help older adults stay longer in their homes and help their family members feel good about it, or at least tolerate it,” Ms. Orlov said.
That will only become more true with the continued proliferation of artificial intelligence, Ms. Orlov added. Some older adults are already using conversational A.I. to get answers about things like the weather or their medications. (Relying too heavily on A.I. can, however, have negative consequences because chatbots often give flawed medical advice and can lead patients astray.) A.I. can also assist in pattern detection: alerting caregivers to signals that might indicate declines in someone’s cognition or mental health, such as changing their speech pattern or leaving the house less frequently.
One A.I.-powered age tech tool is ElliQ, a tabletop companion robot that looks like a sleek silver desk lamp with a screen. About a year and a half ago, Camille Wolsonovich got one for free, thanks to a local nonprofit, for her 90-year-old father, Bill Castellano. He lives alone in a senior community.
Ms. Wolsonovich, who runs a consulting business, relies on ElliQ to lead her father in exercises and remind him to take his pills and drink water. The robot also asks her father about his sleep and mood via automated check-ins.
“Everything’s just another layer that gives us more confidence, from a caregiving standpoint, that he’s good,” Ms. Wolsonovich said. “I don’t have to necessarily track everything all the time and be overbearing.”
As for Mr. Castellano? He plays trivia digitally and converses daily with ElliQ. The robot, which has a friendly female voice, asks questions, cracks jokes and remembers his likes, dislikes and friends. “She’s great company,” he said. “Everybody around me wants one.”
What about ethical concerns?
Clara Berridge studies the ethics of age tech at the University of Washington.
She has many privacy concerns, namely that most direct-to-consumer products aren’t subject to medical privacy laws, despite being privy to sensitive health information. Though she hopes the federal government will eventually step in to regulate these products, as it has in other countries, the onus remains on the consumer for now.
And even if an age tech product isn’t selling mom’s personal data to the lowest bidder, Dr. Berridge said there’s still the question of whether certain tools are ethical.
“It’s really important for caregivers to recognize that using these new technologies that give them more information about someone can represent greater intrusion into someone’s life,” she said.
What may be well-intentioned monitoring could reveal information that an older adult would rather keep private, such as issues with incontinence, or the comings and goings of a romantic partner.
“It can lead to somebody feeling infantilized,” Dr. Berridge said. “Like there’s not a place to hide within your own home.”
Her research shows that adult children often underestimate how much their parents can understand about technology and how much they want to be involved in tech-related decisions.
She encouraged caregivers to have transparent conversations about privacy implications and to avoid ultimatums or the idea that any decision must be permanent. She said caregivers should put themselves in their parents’ shoes: Is this something they’d want their own children monitoring?
Dr. Berridge is working on an advanced directive for technology, which outlines older people’s wishes for how technology is used in their care. Ultimately, she hopes that questions about age tech will become a standard part of planning for the future.
“If you’re at the start of what, for many people, ends up being a long road of supporting someone potentially through the end of their life,” she said, “seeking to understand each other’s concerns and priorities better is time very well spent.”
-
West Virginia4 minutes agoWV officials mark Go Orange Day, urge work zone safety – WV MetroNews
-
Wyoming9 minutes agoWyoming State Parks solicits proposals for appraisals at HSSP
-
Crypto16 minutes agoSouth Korea BOK Governor Prioritizes Digital Won CBDC in First Policy Speech
-
Finance22 minutes agoYes, retail investment needs a boost – but the squirrel looks too tame | Nils Pratley
-
Fitness28 minutes agoExtreme fitness, viral videos could be boosting ‘rhabdo’ cases, health experts say | Globalnews.ca
-
Movie Reviews40 minutes agoMichael Jackson documentary set to release after massive re-write
-
World52 minutes agoIsraeli Strikes Kill a Journalist and Injure Another in Lebanon
-
News58 minutes agoNot a Deal-Breaker: White House Downplays Iranian Action Near the Strait